Controlled release of ionic compounds from poly (L-lactide) microspheres produced by precipitation with a compressed antisolvent

Journal of Controlled Release

Volumn 44, Issue 1, 1997, Pages 77-85

  Falk, Rick ^a   Randolph, Theodore W ^a   Meyer, Jeffrey D ^b   Kelly, R Michael ^b   Manning, Mark C ^b  

^a UCB 428   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Hydrophobic ion pairing; Supercritical; Sustained drug delivery

Indexed keywords

GENTAMICIN; MICROSPHERE; NALOXONE; NALTREXONE; POLYLACTIDE; RIFAMPICIN;

ARTICLE; DRUG RELEASE; ENCAPSULATION; PRIORITY JOURNAL; SUSTAINED RELEASE PREPARATION;

EID: 0031031843     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(96)01508-8     Document Type: Article

References (31)

1. Y.W. Chien, Novel Drug Delivery Systems, 2nd edn. Marcel Dekker, NY. 1992.
2. T. Park, M. Alonso, and R. Langer, Controlled release of proteins from poly (L-lactic acid) coated polyisobutylcyanoacrylate microspheres. J. App. Polymer Sci. 52 (1994) 1797-1807.
3. I. Soriano, A. Delgado, R.V. Diaz and C. Evora, Use of surfactants in polylactic acid protein microspheres. Drug Dev. and Ind. Pharm. 21 (1995) 549-558
4. W. Lu and T. Park, In vitro release profiles of eristostatin from biodegradable polymeric microspheres: protein aggregation problem. Biotechnol. Prog. 11 (1995) 224-227.
5. Y. Tabata and Y. Ikada, Synthesis of gelatin microspheres containing interferon. Pharm. Res. 6 (1989) 422-427.
6. M.S. Hora, R.K. Rana, J.H. Nunberg, T.R. Tice, R.M. Gilley, and M.E. Hudson, Release of human serum albumin from poly (lactide-co-glycolide) microspheres. Pharm. Res. 7 (1990) 1190-1194.
7. T. Niwa, H. Takeuchi, T. Hino, N. Kunou and Y. Kawashima, In vitro drug release behavior of D,L-lactide/glycolide copolymer (PLGA) nanospheres with naferelin acetate prepared by a novel spontaneous emulsification solvent diffusion method. J. Pharm. Sci. 83 (1994) 727-732.
8. T. Heya, H. Okada, Y. Ogawa and H. Toguchi, In vitro and in vivo evaluation of thyrotropin releasing hormone release from copoly (DL-lactic/glycolic acid) microspheres. J. Pharm. Sci. 83 (1994) 636-640.
9. R. Bodmeier, H. Wang, D.J. Dixon, S. Mawson and K.P. Johnston, Polymeric microspheres prepared by spraying into compressed carbon dioxide. Pharm. Res. 12 (1995) 1211-1217.
10. S. Yeo, P.G. Debenedetti, S.Y. Patro and T.M. Przybycien, Secondary structure characterization of microparticulate insulin powders. J. Pharm. Sci. 83 (1994) 1651-1656.
11. L. Brannon-Peppas, Recent advances on the use of biodegrable microparticles and nanoparticles in controlled drug delivery. Int. J. Pharmaceutics 116 (1995) 1-9.
12. J. Tom, G. Lim, P. Debenedetti and R. Prudhomme, Application of supercritical fluids in the controlled release of drugs. In: E. Kiran and J. Brennecke (Eds.) Supercritical Fluid Engineering Science. ACS Symposium Series 514. American Chemical Society, Washington DC, 1993.
13. J. Tom and P. Debenedetti, Formation of bioerodible microspheres and microparticles by rapid expansion of supercritical solutions. Biotechnol. Prog. 7 (1991) 403-411.
14. J. Tom and P. Debenedetti, Particle formation with supercritical fluids - a review. J. Aerosol Sci. 22 (1991) 555-584.
15. M. McHugh and V. Krukonis, Supercritical Fluid Extraction, 2nd edn. Butterworth-Heineman, Stoneham MA, 1994.
16. T.W. Randolph, A.D. Randolph, M. Mebes and S. Yeung, Sub-micrometer-sized biodegradable particles of poly (L-lactic acid) via the gas antisolvent spray precipitation process. Biotechnol. Prog. 9 (1993) 429-435.
17. T.W. Randolph, M.C. Manning, E. Shefter and R.F. Falk, Method for producing ultrafine pharaceutical powders using a compressed gas antisolvent, filed as a continuation-in-part of PCT Int. Pat. Appl. WO 94 08577, June 7, 1994.
18. M. Jackson and H.H. Mantsch, Beware of proteins in DMSO. Biochim. Biophys. Acta 1078 (1991) 231-235.
19. S.N. Timasheff, Protein-solvent interactions and protein conformation. Biochemistry 3 (1970) 62-68.
20. J.D. Meyer, J.E. Matsuura, B.S. Kendrick, E.S. Evans, G.J. Evans and M.C. Manning, Solution behavior of α-chymo-trypsin dissolved in nonpolar organic solvents via hydrophobic ion pairing. Biopolymers 35 (1995) 451-456.
21. J. Matsuura, M.E. Powers, M.C. Manning and E. Shefter, Structure and stability of insulin dissolved in 1-octanol. J. Am. Chem. Soc. 115 (1993) 1261-1264.
22. M.E. Powers, J. Matsuura, M.C. Manning and E. Shefter, Enhanced solubility of proteins and peptides in nonpolar solvents though hydrophobic ion pairing. Biopolymers 33 (1993) 927-932.
23. The Merck Index, 11th edn. Merck and Co. Rahway, NJ, 1989.
24. S.S. Sampath and D.H. Robinson, Comparison of new and existing spectrophotometric methods for the analysis of tobramycin and other aminoglycosides. J. Pharm. Sci. 79 (1990) 428-431.
25. X. Zhang, U.P. Wyss, D. Pichora and M.F.A. Goosen, Biodegradable controlled antibiotic release devices for osteomyelitis: optimization of release properties. J. Pharm. Pharmacol. 46 (1994) 718-724.
26. P. Zuccaro, I. Altieri, P. Betto, R. Pacifici and G. Ricciarello, Determination of naltrexone and 6b-naltrexol in plasma by high-performance liquid chromatography with coulometric detection. J. Chromatogr. 567 (1991) 485-490.
27. T. Higuchi, Mechanism of sustained-action medication: theoretical analysis of rate of release of solid drug dispersed in solid matrices. J. Pharm. Sci. 52 (1963) 1145-1149.
28. J. Maduit, N. Bukh and M. Vert, Gentamycin/poly (lactic acid) blends aimed at sustained release local antibiotic therapy administered per-operatively. I. The case of gentamycin base and gentamycin sulfate in poly (DL-lactic acid) oligomers. J. Controlled Rel. 23 (1993) 209-220.
29. J. Maduit, N. Bukh and M. Vert, Gentamycin/poly (lactic acid) blends aimed at sustained release local antibiotic therapy administered per-operatively. II. The case of gentamycin base and gentamycin sulfate in poly (DL-lactic acid) oligomers. J. Controlled Rel. 23 (1993) 221-230.
30. J. Maduit, N. Bukh and M. Vert, Gentamycin/poly (lactic acid) blends aimed at sustained release local antibiotic therapy administered per-operatively. III. The case of gentamycin base and gentamycin sulfate in poly (DL-lactic acid) oligomers. J. Controlled Rel. 25 (1993) 43-49.
31. W. Fischer and B.W. Muller, U.S. Patent 5,043,280 (1991), Eur. Patent 3,744,329, 1989.